Endorectal magnetic resonance imaging and spectroscopy for the detection of tumor foci in men with prior negative transrectal ultrasound prostate biopsy.
暂无分享,去创建一个
W S Ng | J S P Yuen | W K O Lau | P. Tan | W. Ng | C. Thng | S. Phee | W. Lau | L. Khin | C H Thng | P H Tan | L W Khin | S J L Phee | D Xiao | C W S Cheng | J. Yuen | D. Xiao | C. Cheng | J.S.P. Yuen | S.J.L. Phee | W.K.O. Lau | C.W.S. Cheng
[1] K. Badani,et al. Prospective evaluation of endorectal magnetic resonance imaging to detect tumor foci in men with prior negative prostastic biopsy: a pilot study. , 2000, The Journal of urology.
[2] W. Catalona,et al. Prostate specific antigen density versus prostate specific antigen slope as predictors of prostate cancer in men with initially negative prostatic biopsies. , 1996, The Journal of urology.
[3] J H Ellis,et al. MR imaging and sonography of early prostatic cancer: pathologic and imaging features that influence identification and diagnosis. , 1994, AJR. American journal of roentgenology.
[4] Kazuto Ito,et al. MR spectroscopy as a reliable diagnostic tool for localization of prostate cancer. , 2002, Anticancer research.
[5] J Kurhanewicz,et al. The prostate: MR imaging and spectroscopy. Present and future. , 2000 .
[6] P. Tan,et al. Improved detection rate of prostate cancer using the 10-core biopsy strategy in Singapore. , 2002, Asian journal of surgery.
[7] S. Sternberg,et al. Diagnostic surgical pathology , 1994 .
[8] W. Ellis,et al. Repeat prostate needle biopsy: who needs it? , 1995, The Journal of urology.
[9] V. Barbetti,et al. Results of rebiopsy for suspected prostate cancer in symptomatic men with elevated PSA levels. , 1997, European urology.
[10] S. Robboy. Diagnostic Surgical Pathology, 3rd ed , 2000 .
[11] P. Carroll,et al. Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. , 1999, Radiology.
[12] J. Vilanova,et al. The value of endorectal MR imaging to predict positive biopsies in clinically intermediate-risk prostate cancer patients , 2001, European Radiology.
[13] J Kurhanewicz,et al. Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. , 2000, The Journal of urology.
[14] Bernd Hamm,et al. Patients with a history of elevated prostate-specific antigen levels and negative transrectal US-guided quadrant or sextant biopsy results: value of MR imaging. , 2002, Radiology.